134 related articles for article (PubMed ID: 2796854)
1. Neuroblastoma screening: the Canadian experience.
Lemieux B; Auray-Blais C; Giguère R; Scriver CR
Med Pediatr Oncol; 1989; 17(5):379-81. PubMed ID: 2796854
[No Abstract] [Full Text] [Related]
2. Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
Auray-Blais C; Giguère R; Lemieux B
Med Pediatr Oncol; 1989; 17(5):364-7. PubMed ID: 2796851
[No Abstract] [Full Text] [Related]
3. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
Woods WG; Tuchman M; Lemieux B
Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
[No Abstract] [Full Text] [Related]
4. False positive results in a neuroblastoma screening programme.
Bell S; Parker L; Craft AW; Dale G; McGill AC; Seviour J; Cole M; Smith J
Med Pediatr Oncol; 1994; 22(3):181-6. PubMed ID: 8272007
[TBL] [Abstract][Full Text] [Related]
5. History and current status of neuroblastoma screening in Japan.
Takeda T
Med Pediatr Oncol; 1989; 17(5):361-3. PubMed ID: 2796850
[No Abstract] [Full Text] [Related]
6. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
Schilling FH; Oberrauch W; Schanz F; Treuner J
Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
[No Abstract] [Full Text] [Related]
8. Can mass screening for neuroblastoma detect patients with low vanillylmandelic acid and high homovanillic acid?
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Acta Paediatr Jpn; 1989 Dec; 31(6):742-4. PubMed ID: 2516402
[No Abstract] [Full Text] [Related]
9. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
10. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
Mathieu P; Philip T; Greffe J; Montegue A; Lacroix C
Clin Chim Acta; 1993 Nov; 220(2):229-32. PubMed ID: 8111967
[No Abstract] [Full Text] [Related]
11. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
[No Abstract] [Full Text] [Related]
12. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
Chauvin F; Mathieu P; Frappaz D; Lasset C; Favrot MC; Greffe J; Esteve J; Thiesse P; Combaret V; Chauvot P; Boschetti R; David L; Brunat-Mentigny M; Philip T
Med Pediatr Oncol; 1997 Feb; 28(2):81-91. PubMed ID: 8986143
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
Lamedica G; Falcone R; De Bernardi B; Canini S
Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
[No Abstract] [Full Text] [Related]
14. Neuroblastoma with N-myc amplification detected by urine: mass screening in infants after the sixth month of life.
Kerbl R; Urban C; Starz I; Ambros IM; Strehl S; Kovar H; Gadner H; Ambros PF
Med Pediatr Oncol; 1993; 21(9):625-6. PubMed ID: 8412992
[No Abstract] [Full Text] [Related]
15. Neuroblastoma: the case for screening infants in North America.
Woods WG; Tuchman M
Pediatrics; 1987 Jun; 79(6):869-73. PubMed ID: 3588142
[TBL] [Abstract][Full Text] [Related]
16. Biochemical screening for neuroblastoma in infants: a feasibility study.
Craft AW; Dale G; McGill A; Seviour J; Spence EM
Med Pediatr Oncol; 1989; 17(5):373-8. PubMed ID: 2796853
[TBL] [Abstract][Full Text] [Related]
17. Screening for neuroblastoma (NB) in North America: the Quebec Project.
Woods WG; Lemieux B; Leclerc JM; Bernstein ML; Brisson L; Brossard J; Brodeur GM; Look AT; Robison LL; Shuster JJ
Prog Clin Biol Res; 1994; 385():377-82. PubMed ID: 7972234
[No Abstract] [Full Text] [Related]
18. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
Sato Y; Hanai J; Takasugi N; Takeda T
Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of screening for neuroblastoma in the north of England.
Craft AW; Parker L; Dale G; McGill AC; Seviour JA; Bell S; Cole M; Smith J
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):337-41. PubMed ID: 1456400
[TBL] [Abstract][Full Text] [Related]
20. Screening for neuroblastoma in the north of England.
Parker L; Craft AW; Dale G; Bell S; Cole M; McGill AC; Seviour JA; Smith J
BMJ; 1992 Nov; 305(6864):1260-3. PubMed ID: 1303649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
